A patient with newly diagnosed non-small cell lung cancer (NSCLC), adenocarcinoma subtype, and a history of COPD presents with weight loss and fatigue. The multidisciplinary team is considering treatment options. As a nurse, what is the priority intervention to address the patient's nutritional needs and improve quality of life?

A) Initiate a high-calorie, high-protein diet plan

B) Recommend a low-sodium, low-fat diet

C) Suggest intermittent fasting to manage weight loss

D) Encourage a vegetarian diet to increase antioxidant intake

A patient with newly diagnosed non-small cell lung cancer (NSCLC), adenocarcinoma subtype, presents with fatigue, weight loss, and evidence of metastatic spread. Which nursing intervention is most appropriate to address the patient's nutritional needs and improve quality of life?

A) Recommend a high-calorie, high-protein diet to support weight maintenance and energy levels.

B) Encourage the patient to eat three large meals daily to ensure adequate nutrient intake.

C) Advise the patient to avoid all dairy products to reduce mucus production.

D) Suggest an increase in fluid intake to at least 3 liters per day to flush out toxins.

A patient with a confirmed malignant pleural effusion is experiencing increased shortness of breath, fatigue, and weight loss. Which nursing intervention is most appropriate to prioritize in this situation to improve the patient's respiratory status and overall comfort?

B) Administer prescribed supplemental oxygen and monitor oxygen saturation levels.

A) Encourage increased oral fluid intake to help with hydration.

B) Administer prescribed supplemental oxygen and monitor oxygen saturation levels.

C) Advise the patient to avoid any physical activity to preserve energy.

D) Educate the patient on deep breathing exercises to improve lung expansion.

A patient with a diagnosis of malignant pleural effusion presents with increased shortness of breath, fatigue, and a persistent dry cough. The latest clinical assessment shows an oxygen saturation of 88% on room air, and the patient is receiving supplemental oxygen. In planning care for this patient, which nursing intervention should be prioritized to address the patient's respiratory status?

B) Position the patient in a high Fowler's position to facilitate lung expansion.

A) Encourage the patient to increase oral fluid intake to thin secretions.

B) Position the patient in a high Fowler's position to facilitate lung expansion.

C) Administer prescribed diuretics to reduce fluid retention.

D) Initiate deep breathing exercises to improve lung capacity.

A patient with a history of cancer and recent thoracentesis for pleural effusion is now exhibiting a low-grade fever, increased white blood cell count, and right-sided chest pain that worsens with deep breathing. As a nurse, what is the priority intervention to address this patient's current symptoms?

B) Administer the prescribed broad-spectrum antibiotics to treat the suspected infection.

A) Increase the patient's supplemental oxygen to improve oxygenation.

B) Administer the prescribed broad-spectrum antibiotics to treat the suspected infection.

C) Encourage deep breathing and coughing exercises to improve lung expansion.

D) Notify the healthcare provider immediately about the new onset of chest pain for further evaluation.

A patient with a history of cancer and pleural effusion has been treated with thoracentesis, supplemental oxygen, and systemic therapy. The patient now presents with a low-grade fever, increased white blood cell count, and right-sided chest pain exacerbated by deep breathing. What is the nurse's priority intervention at this time?

C) Monitor vital signs closely and prepare for possible diagnostic tests.

A) Increase the patient's oxygen flow rate to improve saturation.

B) Administer prescribed analgesics for chest pain relief.

C) Monitor vital signs closely and prepare for possible diagnostic tests.

D) Educate the patient on the importance of completing the antibiotic course.

A patient undergoing systemic cancer treatment has developed pneumonia and pleural effusion, accompanied by an elevated white blood cell count and fever. Blood cultures identified a Gram-negative organism, leading to an adjustment in the antibiotic regimen. Which nursing action is most important to prioritize when managing this patient’s care?

D) Coordinating with the pharmacy to adjust the timing of antibiotic administration to avoid interaction with cancer therapy.

A) Monitoring the patient's liver function tests to assess for potential hepatotoxicity from the antibiotics.

B) Ensuring the patient is positioned semi-upright to facilitate lung expansion and drainage.

C) Administering antipyretics around the clock to control the patient's fever.

D) Coordinating with the pharmacy to adjust the timing of antibiotic administration to avoid interaction with cancer therapy.

A patient with cancer is receiving modified antibiotic therapy for a suspected Gram-negative pneumonia. Which nursing intervention is most important to implement to monitor the effectiveness of the treatment?

B) Assess lung sounds and respiratory effort every 4 hours.

A) Monitor vital signs every shift for changes in temperature.

B) Assess lung sounds and respiratory effort every 4 hours.

C) Measure daily intake and output to evaluate fluid balance.

D) Evaluate the patient's nutritional intake and weight weekly.

A patient with a history of cancer and recent antibiotic therapy adjustment presents with respiratory distress and peripheral edema. The arterial blood gas analysis shows respiratory acidosis, and the patient has a low serum albumin level. What is the most appropriate initial nursing intervention to address the patient's respiratory status?

B) Initiate supplemental oxygen therapy to improve oxygen saturation

A) Administer intravenous diuretics to reduce fluid overload

B) Initiate supplemental oxygen therapy to improve oxygen saturation

C) Encourage ambulation to enhance respiratory function

D) Prepare the patient for invasive mechanical ventilation

A patient with cancer has developed respiratory distress and peripheral edema following an adjustment in their antibiotic regimen. The patient exhibits a respiratory rate of 28 breaths per minute, use of accessory muscles, and an oxygen saturation of 88% on room air. Arterial blood gases show a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg. What is the most appropriate initial nursing intervention to address the patient's respiratory status?

A) Initiate high-flow nasal cannula oxygen therapy

B) Administer a bronchodilator to relieve respiratory distress

C) Elevate the head of the bed and encourage deep breathing exercises

D) Notify the healthcare provider for possible intubation and mechanical ventilation

lung cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutations in lung cells lead to uncontrolled cell growth, often triggered by carcinogens like tobacco smoke. These mutations typically affect tumor suppressor genes and oncogenes, disrupting normal cell cycle regulation and promoting cancerous growth.

• Secondary mechanism: Angiogenesis, the formation of new blood vessels, is stimulated by cancer cells to supply the growing tumor with oxygen and nutrients. This process is crucial for tumor survival and expansion within the lung tissue.

• Key complication: Metastasis occurs when cancer cells invade surrounding tissues and enter the bloodstream or lymphatic system, spreading to distant organs. This complicates treatment and significantly affects prognosis, as metastatic lung cancer is often more challenging to manage.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Chronic obstructive pulmonary disease (COPD), hypertension

• Current medications: Albuterol inhaler, lisinopril, atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Weight loss, fatigue, occasional chest pain, hemoptysis

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 100.1°F, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the medical team proceeded with further diagnostic imaging to better understand the extent of the disease. A CT scan of the chest revealed a 4 cm mass in the right upper lobe of the lung, with evidence of mediastinal lymphadenopathy. Additionally, small nodules were noted in the left lung, raising concern for potential bilateral involvement. A PET scan was subsequently performed, confirming increased metabolic activity in these areas, suggestive of malignancy. A biopsy of the lung mass confirmed non-small cell lung cancer (NSCLC), adenocarcinoma subtype. Laboratory tests showed elevated levels of carcinoembryonic antigen (CEA), a tumor marker often associated with lung cancer, further substantiating the diagnosis.

The diagnostic results indicate a high likelihood of metastatic spread, particularly given the bilateral lung involvement and lymphadenopathy. This finding complicates the treatment plan, necessitating a multidisciplinary approach that includes oncology, pulmonology, and palliative care teams. Given the patient's history of COPD, the medical team must carefully consider treatment options that balance efficacy with the potential for exacerbating existing respiratory issues. The patient's continued weight loss and fatigue suggest a need for nutritional support and possibly the introduction of palliative measures to improve quality of life.

These findings underscore the importance of timely intervention and comprehensive management, as the aggressive nature of the disease poses significant challenges. The focus now shifts to determining the most appropriate therapeutic strategy, considering the patient's overall health status and comorbidities. This will likely involve discussions about chemotherapy, targeted therapy, and possibly immunotherapy, in conjunction with supportive care to address symptoms and maintain functional status. The unfolding case highlights the need for ongoing monitoring and adjustment of the care plan as new information becomes available.

Section 2

Change in Patient Status:

A week into the treatment plan, the patient started experiencing increased shortness of breath and a persistent dry cough. During a routine follow-up appointment, the clinical assessment revealed an oxygen saturation of 88% on room air, necessitating supplemental oxygen to maintain adequate levels. The patient also reported increased fatigue and a reduced appetite, contributing to further weight loss. Upon physical examination, decreased breath sounds and dullness to percussion were noted on the right side, indicating a potential pleural effusion.

In response to these findings, the medical team ordered a chest X-ray, which confirmed a moderate pleural effusion on the right side. A thoracentesis was performed, yielding a straw-colored fluid that was sent for cytological analysis. The results suggested malignant pleural effusion, indicating further progression of the disease. The patient's laboratory work showed a slight increase in white blood cell count and elevated inflammatory markers, raising concerns for potential infection or inflammatory response secondary to the effusion.

This change in the patient's status necessitates an immediate revision of the treatment plan. The addition of diuretics and a possible increase in palliative measures are being considered to manage symptoms and improve the patient's quality of life. The oncology team is evaluating the potential benefits of initiating or adjusting systemic therapy to address the cancer's progression while minimizing adverse effects on pulmonary function. This situation underscores the importance of dynamic care management and coordinated efforts among the healthcare team to address both the malignant and symptomatic aspects of the patient's condition.

Section 3

Response to Interventions:

Following the thoracentesis and the initiation of supplemental oxygen, the patient's shortness of breath showed slight improvement, with oxygen saturation levels rising to 92% on 2 liters of oxygen via nasal cannula. However, the patient's fatigue persisted, and despite the use of diuretics, there was minimal reduction in the pleural effusion size upon follow-up imaging. The oncology team decided to adjust the systemic therapy, opting to include a targeted therapy regimen aimed at the specific genetic markers identified in the patient's tumor profile. This approach was chosen to potentially slow the progression of cancer while minimizing additional pulmonary stress.

Despite these interventions, the patient began to exhibit signs of a new complication. The patient developed a low-grade fever of 100.6°F (38.1°C), coupled with an increase in the white blood cell count to 15,000/mm³, suggestive of an infectious process. Blood cultures were taken, and broad-spectrum antibiotics were initiated empirically to address the potential infection. Additionally, the patient reported new onset of right-sided chest pain, exacerbated by deep breathing, which raised clinical suspicion for pleuritis as a complication of the pleural effusion or as a reaction to the malignant process.

These developments highlight the need for close monitoring and further diagnostic evaluation to distinguish between infectious and non-infectious causes of the patient's symptoms. The healthcare team is tasked with balancing aggressive cancer management with symptom control to maintain the patient's quality of life. This situation requires careful consideration of the patient's overall condition, including the potential benefits and risks of continued systemic therapy, in light of the evolving clinical picture. The next steps will involve reassessment of the treatment strategy to address both the infection and cancer progression effectively.

Section 4

New Diagnostic Results:

Following the initiation of broad-spectrum antibiotics, the healthcare team prioritized obtaining additional diagnostic results to clarify the cause of the patient's recent symptoms. A repeat chest X-ray was performed, revealing an increase in the opacification of the right lower lobe, suggesting the development of a pneumonia superimposed on the existing pleural effusion. This finding was consistent with the patient's elevated white blood cell count and fever, indicating an infectious process potentially secondary to the compromised pulmonary function and immunosuppression from systemic cancer treatment.

Further, the results of the blood cultures identified a Gram-negative organism, prompting a modification of the antibiotic regimen to target the specific pathogen more effectively. This adjustment was crucial in addressing the infection while minimizing the risk of antibiotic resistance and potential side effects. Additionally, a CT scan of the chest was ordered to provide a more detailed view of the pleural space and lung parenchyma, aiming to assess for any signs of abscess formation or necrotic tissue, which would require different management strategies.

These diagnostic findings necessitate a reassessment of the patient's treatment plan, balancing the need to manage the infection aggressively with the ongoing cancer therapy. The healthcare team must consider the potential interactions between antibiotics and the targeted cancer therapy, as well as the patient's overall nutritional and hydration status, which could impact recovery. Close interdisciplinary collaboration will ensure that the adjustments to the treatment regimen are made promptly, with the goal of stabilizing the patient's condition and paving the way for potential improvement in both infection control and cancer management.

Section 5

New Complications:

Several days after the adjustment of the antibiotic regimen, the patient began to exhibit signs of respiratory distress, characterized by an increased respiratory rate of 28 breaths per minute, use of accessory muscles, and a drop in oxygen saturation to 88% on room air. Despite initial improvement in fever and white blood cell count, these new symptoms suggest an exacerbation of the underlying pulmonary condition. Arterial blood gases were obtained, revealing a respiratory acidosis with a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg. These findings indicate impaired gas exchange and the need for supplemental oxygen therapy to maintain adequate oxygenation.

In addition to respiratory complications, the patient developed peripheral edema and a weight gain of 2 kg over the past 48 hours, raising concerns about fluid overload possibly due to the intravenous administration of fluids and decreased mobility. A serum albumin level was checked and found to be low at 2.5 g/dL, suggesting a combination of malnutrition and potential liver dysfunction secondary to cancer progression. This hypoalbuminemia may contribute to third-spacing of fluids and further complicate the patient's respiratory status by increasing pleural effusion.

The healthcare team must now consider the implications of these new complications on the patient's overall treatment strategy. A multidisciplinary approach is essential to address the respiratory distress through potential non-invasive ventilation support and diuretics to manage fluid overload. Nutritional support should be optimized to improve protein levels and overall nutritional status, which may aid in better recovery and response to cancer treatment. Close monitoring of the patient's hemodynamic status and daily weights will be crucial in guiding ongoing management and preventing further deterioration.